US · 21 CFR
Personnel responsibilities.
6 findings citing this section, drawn from 5 published documents. The most recent cases are below; the full set is in search.
Search all 21 CFR 211.28 findingsYour firm failed to ensure that manufacturing personnel wear clothing appropriate to protect drug product from contamination (21 CFR 211.28(a)).
See every finding in this document View the regulator's official sourceYour firm failed to ensure that manufacturing personnel wear clothing appropriate to protect drug product from contamination (21 CFR 211.28(a)).
See every finding in this document View the regulator's official sourceYour firm failed to ensure that manufacturing personnel wear clothing appropriate to protect drug product from contamination (21 CFR 211.28(a)).
See every finding in this document View the regulator's official sourceYour firm failed to ensure that manufacturing personnel wear clothing appropriate to protect drug product from contamination (21 CFR 211.28(a)).
See every finding in this document View the regulator's official sourceYour firm failed to ensure that only personnel authorized by supervisory personnel enter those areas of the buildings and facilities designated as limited-access areas (21 CFR 211.28(c)).
See every finding in this document View the regulator's official sourceYour firm failed to ensure that manufacturing personnel wear clothing appropriate to protect drug product from contamination (21 CFR 211.28(a)).
See every finding in this document View the regulator's official sourceThese findings are a record of the moment each document was published. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out — do not read them as the current state; check the regulator's official announcements for the latest status. Findings are extracted automatically from the regulator's published documents, and section citations are counted exactly as written in the source. “View official source” on each case links directly to that document.
Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.
Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.
Click the confirmation button in the email. It's sent from GRM Solutions Brief. If you don't see it, check your spam folder.
Growth stages previewSolve a quiz to start hatching
Your growth record is stored safely in this browser.
